Research, Abstracts and Poster Hall
A Real-World Retrospective Study Evaluating a Team-Based Patient Engagement Approach to Selexipag Initiation and Maintenance in Pulmonary Arterial Hypertension (TEAM PAH)
This real-world chart review study describes oral selexipag titration patterns in patients with pulm ..
Amanda Schnell Heringer RN, AGCNS-BC
University of California, San Francisco Medical Center
Advancing Pulmonary Hypertension Care: Clinical Success with a Novel Drug Class
This single center piloted adding a new class of a PAH medication, an activin signaling inhibitor to ..
Angela Kraus FNP-BC
Advocate Aurora St. Luke's Medical Center
Best practices for managing cough in PAH patients receiving inhaled therapies
n/a ..
Jordin Rice MSN, APRN, AGACNP-BC
National Jewish Hospital, Denver, CO, USA (since March 2025, employee of Gossamer Bio, Inc., San Die
(+
(2)
speakers)
BREEZE Optional Extension Phase: Long-Term Outcomes with Tyvaso DPI in Patients with Pulmonary Arterial Hypertension
N/A ..
Claire Thrasher PharmD, MS
United Therapeutics Corporation
(+ 1 speaker)
1
